Initiator Pharma Stock Forward View - Simple Regression
| INIT Stock | 3.08 -0.02 -0.65% |
Initiator Pharma AS's Simple Regression forecast reference data is generated from the equity's historical trading prices. This page presents the model output and associated accuracy measures as reference information.
The Simple Regression forecasted value of Initiator Pharma AS on the next trading day is expected to be 3.07 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 5.01.In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Initiator Pharma AS historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data. The Simple Regression projections for Initiator Pharma AS are reference data based on historical daily prices and are provided as informational context. Simple Regression Price Forecast For the 19th of March
Given 90 days horizon, the Simple Regression forecasted value of Initiator Pharma AS on the next trading day is expected to be 3.07 with a mean absolute deviation of 0.08 , mean absolute percentage error of 0.01 , and the sum of the absolute errors of 5.01 .Please note that although there have been many attempts to predict Initiator Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Initiator Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Initiator Pharma | Initiator Pharma Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Initiator Pharma AS focuses on identifying predictive downside and upside bands that can frame a realistic trading range. Used properly, these levels provide context around forecast dispersion rather than certainty about the next closing print.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Initiator Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Initiator Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.7365 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0808 |
| MAPE | Mean absolute percentage error | 0.0264 |
| SAE | Sum of the absolute errors | 5.0098 |
Other Forecasting Options for Initiator Pharma
The price trajectory of Initiator is the primary concern for any investor assessing it as an opportunity. Initiator Stock price charts are filled with noise that can easily mislead uninformed investment decisions.Initiator Pharma Related Equities
The following equities are related to Initiator Pharma within the Biotechnology space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Initiator Pharma against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Initiator Pharma Market Strength Events
Understanding the market strength of Initiator Pharma stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in Initiator Pharma AS with greater precision.
Initiator Pharma Risk Indicators
Reviewing Initiator Pharma's basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding Initiator Pharma's and informs decisions about hedging and position.
| Mean Deviation | 2.12 | |||
| Semi Deviation | 2.46 | |||
| Standard Deviation | 3.14 | |||
| Variance | 9.85 | |||
| Downside Variance | 7.38 | |||
| Semi Variance | 6.04 | |||
| Expected Short fall | -2.99 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Initiator Pharma
The amount of media and story coverage tied to Initiator Pharma AS can signal where market attention is concentrating at the moment. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Initiator Pharma Short Properties
Reviewing short-oriented indicators for Initiator Pharma AS is useful because long and short participants often create very different signals for timing and volatility. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 47.9 M | |
| Cash And Short Term Investments | 34.1 M |
Additional Tools for Initiator Stock Analysis
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing |